Is there still a role of plasma exchange in the current management of ANCA-associated vasculitides?

Task Toyoda, Max Yates, Richard A. Watts

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)
1 Downloads (Pure)

Abstract

Cost utility analysis and trials including patient-centred outcomes are required to evaluate the use of PLEX. Furthermore, ascertaining those at high risk of developing ESRF could help identify those who may benefit from PLEX the most, and further insights are required in setting of diffuse alveolar haemorrhage.
Original languageEnglish
Pages (from-to)111-117
Number of pages7
JournalCurrent Rheumatology Reports
Volume24
Issue number4
Early online date22 Mar 2022
DOIs
Publication statusPublished - Apr 2022

Keywords

  • ANCA-associated vasculitis
  • Diffuse alveolar haemorrhage
  • End-stage renal failure
  • Plasma exchange

Cite this